Please select the option that best describes you:
Topics:
Gynecologic Oncology • Endometrial Cancer
For a recurrent, MSI-H endometrial cancer, do you usually treat with Pembrolizumab alone or in combination with Lenvatinib?
Answer from: at Community Practice
Alone.
Sign in or Register to read more